Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey

Bibliographic Details
Main Authors:	Argyris Tzouvelekis, Demosthenes Bouros
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396419308011

Similar Items

Serum biomarkers in interstitial lung diseases
by: Anevlavis Stavros, et al.
Published: (2005-07-01)

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
by: Anevlavis Stavros, et al.
Published: (2006-05-01)

Progressive fibrotic interstitial lung disease
by: Carlos A C Pereira, et al.
Published: (2023-08-01)

Formoterol in the management of chronic obstructive pulmonary disease
by: Paschalis Steiropoulos, et al.
Published: (2008-06-01)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
by: Argyris Tzouvelekis, et al.
Published: (2020-04-01)

Bridges of Pulmonology 2023 proceedings: Highlights in the field of interstitial lung diseases
by: Vasilina Sotiropoulou, et al.
Published: (2024-03-01)

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
by: Amy Hajari Case
Published: (2022-03-01)

Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
by: Pneumatikos Ioannis, et al.
Published: (2005-06-01)

Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
by: Vasilios Tzilas, et al.
Published: (2020-11-01)

Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies
by: Vasilios Tzilas, et al.
Published: (2024-04-01)

Factors associated with rapid progression in fibrotic interstitial lung disease
by: Xianqiu Chen, et al.
Published: (2023-12-01)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
by: Vasilios Tzilas, et al.
Published: (2017-09-01)

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
by: Antoniya Kamenova, et al.
Published: (2023-03-01)

Clinical Impact of Physical Activity and Cough on Disease Progression in Fibrotic Interstitial Lung Disease
by: Tobias Veit, et al.
Published: (2023-05-01)

Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases.
by: Gian Luca Casoni, et al.
Published: (2014-01-01)

Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease
by: Kristin Berger, et al.
Published: (2023-02-01)

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
by: Anevlavis Stavros, et al.
Published: (2004-11-01)

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
by: Sabina A. Guler, et al.
Published: (2022-06-01)

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
by: Lutz B. Jehn, et al.
Published: (2023-02-01)

The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease—A Systematic Review
by: Ruxandra Puiu, et al.
Published: (2024-02-01)

Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
by: Anna Valeria Samarelli, et al.
Published: (2021-08-01)

Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases
by: Evgeniy I. Shchepikhin, et al.
Published: (2023-04-01)

Metabolic Disorders in Chronic Lung Diseases
by: Ourania Papaioannou, et al.
Published: (2018-01-01)

Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives
by: Vincent Cottin, et al.
Published: (2022-09-01)

Fibrotic interstitial lung diseases and air pollution: a systematic literature review
by: Sergio Harari, et al.
Published: (2020-08-01)

Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
by: Karim Boustani, et al.
Published: (2022-02-01)

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
by: Ole Hilberg, et al.
Published: (2022-01-01)

Harnessing PM2.5 Exposure Data to Predict Progression of Fibrotic Interstitial Lung Diseases Based on Telomere Length
by: Jessica Germaine Shull, et al.
Published: (2022-05-01)

The “silent threat” of nocturnal hypoxia remains unresolved for patients with fibrotic interstitial lung diseases
by: Atsushi Suzuki
Published: (2024-02-01)

Characteristics of pulse oximetry and arterial blood gas in patients with fibrotic interstitial lung disease
by: Deborah Assayag, et al.
Published: (2024-03-01)

Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review
by: Sabrina Carvajalino, et al.
Published: (2018-05-01)

Reliability of histopathologic diagnosis of fibrotic interstitial lung disease: an international collaborative standardization project
by: Robert Camp, et al.
Published: (2021-06-01)

“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
by: Giacomo Sgalla, et al.
Published: (2018-06-01)

A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
by: Alyson W. Wong, et al.
Published: (2020-12-01)

Lung proteome and metabolome endotype in HIV-associated obstructive lung disease
by: Sarah Samorodnitsky, et al.
Published: (2023-03-01)

Editorial: Fibrotic Lung Disease—“Lumping” the Progressive Phenotype
by: Tejaswini Kulkarni, et al.
Published: (2022-05-01)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
by: Reoto Takei, et al.
Published: (2023-06-01)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2020-02-01)

Increased monocyte level is a risk factor for radiological progression in patients with early fibrotic interstitial lung abnormality
by: Andrew Achaiah, et al.
Published: (2022-07-01)

Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases
by: Kawano-Dourado, L, et al.
Published: (2024)